medigraphic.com
ISSN 0185-6014 (Print)
Órgano oficial de difusión de la Federación Mexicana de Patología Clínica, AC y de la Asociación Latinoamericana de Patología Clínica/Medicina de Laboratorio

2017, Number 4

<< Back Next >>

Rev Mex Patol Clin Med Lab 2017; 64 (4)

Report of cervico-vaginal infections associated with HIV patients

Sánchez-Hernández JA, Rivera-Tapia JA, Meléndez-García I, Huerta-Romano JF, Muñoz-Zurita G

Language: Spanish
References: 25
Page: 181-184
PDF size: 215.69 Kb.


ABSTRACT

An estimated 2.5 million people are infected with human immunodeficiency virus (HIV) in a year. Immunodeficiency caused by chronic HIV infection increases the risk of co-infection with pathogens that are usually controlled by the immune systems; within these pathogens are four that are causing the most common cervical-vaginal infections: human papillomavirus (HPV), Gardnerella vaginalis, Trichomonas vaginalis and Candida spp sectional, descriptive and observational study in which 41 patients were study HIV positive confirmed by Western blot exfoliative cytology (Pap) performed, the samples were processed and stained by the Papanicolaou stain train modified for subsequent microscopic diagnosis. An incidence of cervicovaginal infection was found in 97.56% of the population; the pathogen was found most frequently HPV PCR confirmed a 75.60% followed by the presence of cocci, candidiasis and trichomoniasis.


REFERENCES

  1. Bekker LG, Beyrer C, Quinn TC. Behavioral and biomedical combination strategies for HIV prevention. Cold Spring Harb Perspect Med. 2012; 2 (8). pii: a007435.

  2. Chang CC, Crane M, Zhou J, Mina M, Post JJ, Cameron BA et al. HIV and co-infections. Immunol Rev. 2013; 254 (1): 114-142.

  3. Guía de práctica clínica para la atención del paciente con infección por el VIH en el primer nivel de atención. México: Secretaría de Salud; 2008.

  4. Rosas-Escareño AN, Hernández-Madrigal PG, Nájar-Guerrero I, Guzmán-Pérez CR, Castañeda-Achutiguí FD. Características estructurales y funcionales del virus de la inmunodeficiencia humana. Enf Inf Microbiol. 2013; 33 (4): 163-173.

  5. Sha BE, Chen HY, Wang QJ, Zariffard MR, Cohen MH, Spear GT. Utility of Amsel criteria, Nugent score, and quantitative PCR for Gardnerella vaginalis, Mycoplasma hominis, and Lactobacillus spp. for diagnosis of bacterial vaginosis in human immunodeficiency virus-infected women. J Clin Microbiol. 2005; 43 (9): 4607-4612.

  6. Yeoman CJ, Yildirim S, Thomas SM, Durkin AS, Torralba M, Sutton G et al. Comparative genomics of Gardnerella vaginalis strains reveals substantial differences in metabolic and virulence potential. PLoS One. 2010; 5 (8): e12411.

  7. Turovskiy Y, Sutyak Noll K, Chikindas ML. The aetiology of bacterial vaginosis. J Appl Microbiol. 2011; 110 (5): 1105-1128.

  8. Coleman JS, Gaydos CA, Witter F. Trichomonas vaginalis vaginitis in obstetrics and gynecology practice: new concepts and controversies. Obstet Gynecol Surv. 2013; 68 (1): 43-50.

  9. Lustig G, Ryan CM, Secor WE, Johnson PJ. Trichomonas vaginalis contact-dependent cytolysis of epithelial cells. Infect Immun. 2013; 81 (5): 1411-149.

  10. Tournu H, Van Dijck P. Candida biofilms and the host: models and new concepts for eradication. Int J Microbiol. 2012; 2012: 845352.

  11. Achkar JM, Fries BC. Candida infections of the genitourinary tract. Clin Microbiol Rev. 2010; 23 (2): 253-273.

  12. Luchters SM, Vanden-Broeck D, Chersich MF, Nel A, Delva W, Mandaliya K et al. Association of HIV infection with distribution and viral load of HPV types in Kenya: a survey with 820 female sex workers. BMC Infect Dis. 2010; 10: 18.

  13. Tratamiento antirretroviral del paciente adulto con infección por el VIH. México: Secretaría de Salud, Guía elaborada en 2008, actualizada en 2011.

  14. Massad LS, Xie X, Darragh T, Minkoff H, Levine AM, Watts DH et al. Genital warts and vulvar intraepithelial neoplasia: natural history and effects of treatment and human immunodeficiency virus infection. Obstet Gynecol. 2011; 118 (4): 831-839.

  15. Jaisamrarn U, Castellsagué X, Garland SM, Naud P, Palmroth J, Del Rosario-Raymundo MR et al. Natural history of progression of HPV infection to cervical lesion or clearance: analysis of the control arm of the large, randomised PATRICIA study. PLoS One. 2013; 8 (11): e79260.

  16. Odida M, Sandin S, Mirembe F, Kleter B, Quint W, Weiderpass E. HPV types, HIV and invasive cervical carcinoma risk in Kampala, Uganda: a case-control study. Infect Agent Cancer. 2011; 6 (1): 8.

  17. Ahmed A, Earl J, Retchless A, Hillier SL, Rabe LK, Cherpes TL et al. Comparative genomic analyses of 17 clinical isolates of Gardnerella vaginalis provide evidence of multiple genetically isolated clades consistent with subspeciation into genovars. J Bacteriol. 2012; 194 (15): 3922-3937.

  18. Diagnóstico y tratamiento de la vaginitis infecciosa en mujeres en edad reproductiva, en el primer nivel de atención. México: Secretaría de Salud; 2009.

  19. Cohen CR, Lingappa JR, Baeten JM, Ngayo MO, Spiegel CA, Hong T et al. Bacterial vaginosis associated with increased risk of female-to-male HIV-1 transmission: a prospective cohort analysis among African couples. PLoS Med. 2012; 9 (6): e1001251.

  20. Taff HT, Mitchell KF, Edward JA, Andes DR. Mechanisms of Candida biofilm drug resistance. Future Microbiol. 2013; 8 (10): 1325-1337.

  21. Junqueira JC, Fuchs BB, Muhammed M, Coleman JJ, Suleiman JM, Vilela SF et al. Oral Candida albicans isolates from HIV-positive individuals have similar in vitro biofilm-forming ability and pathogenicity as invasive Candida isolates. BMC Microbiol. 2011; 11: 247.

  22. Gupta P. Hepatitis C virus and HIV type 1 co-infection. Infect Dis Rep. 2013; 5 (Suppl 1): e7.

  23. Day TA, Kublin JG. Lessons learned from HIV vaccine clinical efficacy trials. Curr HIV Res. 2013; 11 (6): 441-449.

  24. Drake AL, Wagner A, Richardson B, John-Stewart G. Incident HIV during pregnancy and postpartum and risk of mother-to-child HIV transmission: a systematic review and meta-analysis. PLoS Med. 2014; 11 (2): e1001608.

  25. Eaton JW, Johnson LF, Salomon JA, Bärnighausen T, Bendavid E, Bershteyn A et al. HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa. PLoS Med. 2012; 9 (7): e1001245.




2020     |     www.medigraphic.com